TCL Archive Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer June 27, 2014
TCL Archive Accelerated Approval Will No Longer Block Competitors, FDA Commissioner Says June 6, 2003
TCL Archive Survival Rates Same For Two Treatments For Eye Cancer: Radiation Or Removal July 27, 2001